Bone Density Changes Following Radiotherapy to Vertebral Metastases

Area of Science:

• Radiology
• Oncology
• Bone Metabolism

Background:

• Increasing patient longevity necessitates better assessment of bone healing after radiotherapy for bone metastases.
• Current methods for evaluating treatment response in bone metastases are often subjective or limited.
• Quantitative assessment of bone changes post-radiotherapy is needed.

Purpose of the Study:

• To quantitate cancer-involved bone changes after radiotherapy using bone mineral density (BMD) changes measured by computed tomography (CT) imaging.
• To explore the relationship between radiotherapy dose and bone density changes.
• To investigate if lesion characteristics influence density changes.

Main Methods:

• Retrospective analysis of 117 spinal metastases treated with radiotherapy.
• CT imaging used to measure bone mineral density (BMD) in various defined volumes (GTV, GBV, Lyt, Domlyt, CBV) before and after treatment.
• Hounsfield density calibration curve applied for quantitative density measurements.

Main Results:

• Significant increases in bone density were observed in gross tumor volume (GTV), gross bone volume (GBV), total lytic volume (Lyt), and dominant lytic volume (Domlyt) post-radiotherapy (p<0.0001).
• The magnitude of density increase varied, with Domlyt > Lyt > GTV > GBV.
• Biologically effective dose (BED) was the only significant factor correlating with GTV density change (p=0.0175).

Conclusions:

• Increases in bone mineral density (BMD) after radiotherapy are associated with bone healing, irrespective of initial lesion size or density.
• CT-based BMD assessment offers a quantitative method to evaluate treatment response in bone metastases.
• Further prospective studies are warranted to correlate early density changes with long-term treatment control.